Beacon secures $170m to advance ophthalmic gene therapies – Pharmaceutical Technology
X-linked retinitis pigmentosa (XLRP) is an incurable genetic disease that causes blindness in men. Credit: Tracy Spohn via Shutterstock. Beacon Therapeutics has raised $170m in